Novo Nordisk A/S
NVO
$127.77
$0.9150.72%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 54.37% | 41.26% | 24.39% | 11.37% | 3.46% |
| Total Depreciation and Amortization | 14.19% | 14.58% | 12.23% | 7.20% | 10.75% |
| Total Amortization of Deferred Charges | 14.80% | -12.89% | -12.89% | -12.89% | -12.89% |
| Total Other Non-Cash Items | 40.64% | 13.27% | 175.31% | 70.76% | 80.37% |
| Change in Net Operating Assets | -164.53% | 82.47% | -394.95% | -185.71% | 49.63% |
| Cash from Operations | 40.77% | 57.31% | 28.14% | 13.11% | 26.93% |
| Capital Expenditure | -120.66% | -130.57% | -145.91% | -112.78% | -68.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 65.43% | 65.43% | 65.43% | 65.43% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -230.80% | -259.58% | -40.14% | -21.29% | 28.90% |
| Cash from Investing | -84.01% | -30.08% | -2.03% | 11.25% | 29.81% |
| Total Debt Issued | -- | -99.60% | -99.73% | -99.80% | -49.39% |
| Total Debt Repaid | 89.23% | 90.29% | 89.98% | 93.51% | -103.66% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -24.24% | -15.14% | -13.96% | -18.34% | -23.85% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -25.46% | -25.46% | -8.39% | -8.39% | -6.08% |
| Other Financing Activities | -- | -- | -- | 60.78% | -- |
| Cash from Financing | -23.78% | -54.95% | -41.43% | -60.44% | -79.42% |
| Foreign Exchange rate Adjustments | 49.98% | -179.26% | -216.92% | -205.08% | -135.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.98% | 193.53% | 68.03% | -77.55% | 419.01% |
